Nigeria approves Zmapp for treatment
BY ABU IDRISU:
NATIONAL Health Research Ethics Committee, a national body under the Federal Ministry of Health, has approved the use of the experimental Ebola virus disease drug, ZMapp, for treatment of patients infected with the virus.
This was revealed in a statement made available to newsmen by the chairman of the committee, Professor Clement Adebamowo, in Abuja, on Wednesday.
This followed the approval of the drug by the World Health Organisation (WHO) for treatment of Ebola patients.
According to the statement, “it is ethical to use these treatments in the current situation without first submitting an application to national, state or institutional health research ethics committee for prior review and approval.”
The committee also waived the current requirement that international shipment of any biological samples out of the country should be preceded by the establishment of a materials transfer agreement to promote rapid international response to the global emergency.
NATIONAL Health Research Ethics Committee, a national body under the Federal Ministry of Health, has approved the use of the experimental Ebola virus disease drug, ZMapp, for treatment of patients infected with the virus.
This was revealed in a statement made available to newsmen by the chairman of the committee, Professor Clement Adebamowo, in Abuja, on Wednesday.
This followed the approval of the drug by the World Health Organisation (WHO) for treatment of Ebola patients.
According to the statement, “it is ethical to use these treatments in the current situation without first submitting an application to national, state or institutional health research ethics committee for prior review and approval.”
The committee also waived the current requirement that international shipment of any biological samples out of the country should be preceded by the establishment of a materials transfer agreement to promote rapid international response to the global emergency.
Post a Comment